Somatrogon以Ngenla为品牌出售，是一种治疗生长激素缺乏症的药物。Somatrogon是一种糖基化蛋白，由人类生长激素和一小部分人绒毛膜促性腺激素组成，后者附着在N 端和C 端。 Somatrogon 是一种人类生长激素类似物。 Somatrogon 于 2021 年 11 月在澳大利亚获准用于医疗用途 ...

Somatrogon以Ngenla为品牌出售，是一种治疗生长激素缺乏症的药物。Somatrogon是一种糖基化蛋白，由人类生长激素和一小部分人绒毛膜促性腺激素组成，后者附着在N 端和C 端。 Somatrogon 是一种人类生长激素类似物。 Somatrogon 于 2021 年 11 月在澳大利亚获准用于医疗用途 ...

Meaghan Senn is a writer from North Carolina with experience in B2B, technology and digital marketing topics. Throughout her career, Meaghan has worked with B2B, software and digital marketing ...

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on ...

Minimum investments vary for each fund, the structure of private equity funds historically follows a framework that includes classes of fund partners, management fees, investment horizons ...

A model showing how metallic bonds are formed - the first diagram shows the outer electrons in their atoms, and the second diagram shows that the electrons have become delocalised ...

A structure being erected alongside the Kerch Bridge in Russian-occupied Crimea has raised questions online. Satellite images show what appears to be a secondary bridge being raised parallel to ...

国家药监局官网显示，诺和诺德的帕西生长素注射液的新药上市申请获得受理。国内生长激素市场以本土企业为主，海外企业影响力及存在感偏弱。业内预测，2024年中国生长激素市场有望达到133.11亿元，面对如此庞大的市场，诺和诺德准备好了吗？ 竞争对手以 ...